Recruiting
Phase 2

EVO756

Sponsor:

Evommune, Inc.

Code:

NCT07616128

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

EVO756, Dose 1

EVO756, Dose 2

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-11. This information was provided to ClinicalTrials.gov by Evommune, Inc. on 2026-08-10.